+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CD3-positive diffuse large B-cell lymphoma relapses as CD3-negative large B-cell lymphoma: Loss of aberrant antigen expression in B-cell lymphoma after chemotherapy



CD3-positive diffuse large B-cell lymphoma relapses as CD3-negative large B-cell lymphoma: Loss of aberrant antigen expression in B-cell lymphoma after chemotherapy



Pathology Research and Practice 214(10): 1738-1744



Aberrant expression of CD3 on diffuse large B-cell lymphoma (DLBCL) is rare, and its mechanism and biological significance are currently unclear. Herein we report a case of Epstein-Barr virus-negative, CD3-positive DLBCL in a 53 year-old male, who had a remote history of renal transplantation. After standard chemotherapy, the patient was in clinical remission. He relapsed three years later, but at this time with apparent loss of CD3 expression. PCR-based IGK gene rearrangement studies demonstrated clonal amplicons with an identical nucleotide size between the primary and secondary DLBCL, confirming the clonal relationship despite their phenotypic differences. To our knowledge, this is the first case of CD3-positive DLBCL that demonstrated a loss of aberrant CD3 on relapse. The chronologic change in phenotype seen in this case suggests that the source of the patient's lymphoma relapse may arise from either a quiescent subclone without CD3 expression, or from an upstream neoplastic precursor cell.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053573134

Download citation: RISBibTeXText

PMID: 30025593

DOI: 10.1016/j.prp.2018.07.003


Related references

Cd30 and Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma With Aberrant T-Cell Marker Expression Arising in Low-Grade Follicular Lymphoma: A Case Report. American Journal of Clinical Pathology 149(Suppl_1): S77-S78, 2018

Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): a case report and review of the literature. Medical Oncology 29(2): 1223-1226, 2012

Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma. Cancer Science 94(9): 774-781, 2003

The histologic, immunohistochemical, and genetic features of classical Hodgkin lymphoma and anaplastic large cell lymphoma with aberrant T-cell/B-cell antigen expression. Human Pathology 84: 309-320, 2019

T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma. Human Pathology 41(9): 1238-1244, 2010

Expression of the AID protein in B-cell non-Hodgkins lymphoma and in distinct subtypes of diffuse large B-cell lymphoma with or without aberrant Somatic Hypermutation. Blood 102(11): 68a, 2003

Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma. American Journal of Hematology 87(8): 770-775, 2012

Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma. Leukemia and Lymphoma 49(7): 1329-1336, 2008

Outcome of salvage therapy for relapsed or refractory peripheral T-cell lymphoma (PTCL), anaplastic large cell lymphoma (ALCL), and diffuse large B-cell lymphoma (DLBCL). Journal of Clinical Oncology 24(18_Suppl): 6544-6544, 2016

MYC Negative Rectal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in an Immunocompetent Patient. Case Reports in Pathology 2013: 302304, 2013

Follicular lymphoma with progression to diffuse large B-cell lymphoma and concurrent CD5-negative mantle cell lymphoma-3 entities in a lymph node. Cancer Control 21(3): 251-254, 2014

Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma. Archives of Pathology & Laboratory Medicine 131(5): 742-747, 2007

Composite lymphoma after chemotherapy with regressed diffuse large B-cell lymphoma and transformed cytotoxic T-cell lymphoma. Leukemia and Lymphoma 54(5): 1101-1104, 2013

Discordant lymphoma of duodenal EBV-positive peripheral T-cell lymphoma not otherwise specified and ileal diffuse large B-cell lymphoma. Japanese Journal of Clinical Hematology 57(4): 445-450, 2016

Follicular large cell lymphoma treated by intensive chemotherapy An analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large cell lymphoma. Blood 86(10 Suppl. 1): 440A, 1995